KEYTRUDA & Role in Stage 4 Melanoma | Immunotherapy has Long-Term Benefits After Treatment

John P. Fruehauf, MD, UC Irvine Health, explains KEYTRUDA & Role in Stage 4 Melanoma | Immunotherapy has Long-Term Benefits After Treatment at MOASC 2018